"Generics account for nine out of every 10 prescriptions filled in the United States. If drug makers are attempting to abuse the patent system to unfairly evergreen their products, they're failing abysmally."
"Activists have focused their ire on a practice they've dubbed 'evergreening.' They claim that pharmaceutical companies game the system by patenting incremental changes to already FDA-approved drugs to delay generic competition."
"Developing new versions of a product that's already on the market is not patent abuse. It's how innovation works in every industry."
"Even after they secure initial FDA approval for a new medicine, they constantly search for new uses for the drug, as well as ways to make it easier to take, reduce its side effects, or increase its effectiveness."
Generics account for 90% of prescriptions filled in the U.S. Brand-name drugmakers are accused of manipulating the patent system to block generics. However, this narrative is challenged by data that contradicts these claims. Weakening patent protections based on misconceptions could hinder lifesaving research without reducing drug prices. The practice of patenting incremental changes in drugs is not abuse but a standard innovation process, similar to advancements in technology and automotive industries. Drug companies continuously seek improvements in their products post-FDA approval.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]